It seems we can’t find what you’re looking for. Perhaps searching can help.
Nothing found
Latest Articles
-
Bristol Myers, Charles River join Series A funding for iVexSol
January 27, 2023 Comments Off on Bristol Myers, Charles River join Series A funding for iVexSolMassachusetts-based iVexSol has secured funding to the tune of $23.8 million in its latest Series A round. The new investors include Bristol Myers Squibb, manufacturer Charles River Laboratories and Asahi Kasei Medical. iVexSol is a manufacturer of lentiviral vectors (LVV), used in making gene therapies, and this latest round of…… Click here to view original post… […]
-
January 27, 2023 Comments Off on BLUE CROSS BLUE SHIELD OF MASSACHUSETTS EXPEDITES ACCESS TO CARE FOR TEXAS MEMBERS AFFECTED BY SEVERE WEATHER
-
January 27, 2023 Comments Off on Senior/ Principal Scientist, Translational Sciences – Morphic Therapeutic Inc – Waltham, MA
-
January 27, 2023 Comments Off on Lab Applications Chemist – Proveris Scientific Corporation – Hudson, MA
-
January 27, 2023 Comments Off on Senior Clinical Trial Manager / Clinical Trial Manager – Kymera Therapeutics – Watertown, MA
Popular Articles
-
Data science gives new insight into air pollution in the US
June 2, 2021 Comments Off on Data science gives new insight into air pollution in the USAt the Henry W. Kendall Memorial Lecture, biostatistician Francesca Dominici illuminates the interplay between air pollution, environmental injustice, and Covid-19. Click here to view original post… […]
-
June 2, 2021 Comments Off on Spending is still on the rise at Mass General Brigham
-
June 2, 2021 Comments Off on Genetic base editing treats sickle cell disease in mice
-
June 2, 2021 Comments Off on Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
June 2, 2021 Comments Off on Kymera Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference